Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Prelude Therapeutics (PRLD) Q4 2022 Earnings
PRLD
15
Mar
Confirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.65
-0.63
-0.6
-0.58
Details
Expected EPS
-0.63
Actual EPS
-0.6
Surprise EPS
0.03
Surprise Percent
+4.76%
Description
Prelude Therapeutics (PRLD) has reported earnings of -0.6 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login